Summary:
Clinical research study to assess the effectiveness and safety of Tildrakizumab in the treatment of moderate to severe nail psoriasis.
Qualified Participants Must:
• Adults, 18 years or older with moderate to severe plaque-psoriasis for at least 6 months and have nail psoriasis involvement
Qualified Participants May Receive:
medical care at no cost and compensation for his/her participation